Trial Profile

Placebo-controlled, Double-blind, Randomized Study of Aerucin as Adjunct Therapy to Antibiotics in the Treatment of P. Aeruginosa Pneumonia

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 25 Jul 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs AR 105 (Primary)
Indications Pseudomonal infections; Ventilator associated pneumonia
Focus Therapeutic Use
Sponsors Aridis Pharmaceuticals

Most Recent Events

03 Sep 2019 Primary endpoint has not been met. (Clinical Cure: treatment success, treatment failure)
03 Sep 2019 Results published in the Media Release
08 Aug 2019 Status changed from active, no longer recruiting to completed.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com